US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Latest News about RDTCF

Recent news which mentions RDTCF

Rapid Dose Therapeutics FY23 Revenue Declines 59%, Here Are The Details
Tickers RDTCF
Tags Markets Earnings premium
From Benzinga
Rapid Dose Therapeutics FY 2022 Revenue Grows 232%, First Three Quarters Of FY 2023 Don't Look As Good
Tickers RDTCF
Tags RDTCF Benzinga News
From Benzinga
Lifeist Wellness Reports Q3 Revenue Growth Led By Its Cannabis Subsidiary, CannMart
Tickers NXTTF RDTCF
Tags Lifeist Wellness Earnings Benzinga News
From Benzinga